We compared other lung cancer biomarkers, vascular endothelial growth factor (VEGF), programmed cell death 1 ligand 1 (PD‐L1), and carcinoembryonic antigen (CEACAM), with Chi3L1 in the serum of lung cancer patients. Here, CEACAM5 is linked to lung carcinoma.